异动个股hgsi出现双底形态

(Reuters) - Shares of biotechnology company Human Genome Sciences Inc (HGSI.O) rose as much as 17.2 percent on Tuesday amid speculation its partner, GlaxoSmithKline Plc (GSK.L), could be poised to make a $25-a-share bid.